Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 17, 2009

Premium

Shaun Lonergan has become CEO of Nerites, which develops new wound adhesives, and has joined the company's board of directors. Most recently, he was vice president of sales, marketing, and business development for Ibis Biosciences, which was sold to Abbott Molecular in January. Prior to that, he held similar positions at 454 Life Sciences and NimbleGen Systems. Earlier, he was vice president of corporate development at Third Wave Technologies.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.